Heather King, PhD, and team argue that to fully evaluate new treatments for Staphylococcus aureus and Gram-negative bacterial bloodstream infections, researchers should measure quality of life, informed directly by patients’ experiences. Read their research that could help engage patients, integrating their experiences into patient care and clinical trials, and the corresponding editorial that supports their findings.